ONCOTHERAPY PLATFORM CAMPANIA

Project

Project co-funded by the European Union, the Italian State and the Campania Region, under the POR Campania FESR 2014-2020, O.S. 1.2.2; 1.1.2 Manifestazione di interesse per la Realizzazione di Technology Platform nell’ambito della lotta alle patologie oncologiche, admitted for funding with D.D. n. 4 of 22/01/2019 by the Campania Region, CUP B61G18000470007

Project
FIGHTING CANCER RESISTANCE: MULTIDISCIPLINARY INTEGRATED PLATFORM FOR AN INNOVATIVE TECHNOLOGICAL APPROACH TO ONCOTHERAPIES

Description
The Campania Oncotherapies Project consists of the Development of a regional integrated multidisciplinary platform for combating cancer drug resistance by:
Development of innovative therapeutic approaches (e.g., cell replacement therapy, innovative vaccines, gene therapy and bacteriophages) for the prophylaxis and/or treatment of drug-resistant cancer diseases.
Identification of tumor-specific biomarkers from samples taken from patients or biobanks
Identification and optimization of experimental protocols alternative to the use of laboratory animals
Identification of new drug targets and their modulators based on existing lines of research and identified biomarkers
Development of innovative noninvasive approaches for preclinical diagnosis, including through sensors and biosensors
Development of innovative formulations for drug-delivery and drug-targeting
Implementation of precision medicine procedures (screening, treatment, clinical outcomes) on the basis of integrated results related to the above points

Objectives
The project aims to activate a new mode of collaboration between the world of research and innovation, with a view to Open Innovation and knowledge sharing, through the systemization of the various regional market players operating in the field of oncology with the goal of fostering a better quality innovation process for the healthcare system. To achieve this goal, the aim is to create a regional testing hub for early cancer identification, characterization of resistance profile and creation of alternative therapies for patients who do not respond to conventional therapies.

Expected Results.
Development of innovative personalized therapeutic approaches for prophylaxis and/or treatment of oncological diseases;
Development of non-invasive approaches for early detection of cancer through sensors and biosensors.

Made by
National Cancer Institute “G. Foundation Pascale” as the proposer

And as partners from:

Clinical Research Technology Srl
Consiglio Nazionale delle Ricerche – IBB
Consiglio Nazionale delle Ricerche – ICAR
Cosvitec Scarl
CSP SpA
Dedalus SpA con Socio Unico
Ehealthnet Scarl
Fondazione Ebris
Fondazione Telethon
Home Medicine Italia Srl
Hosmotic Srl
IGEA SpA
Istituto Zooprofilattico Sperimentale del Mezzogiorno – Dipartimento di Sanità Animale
Kelyon Srl
Mater Scarl
Pineta Grande SpA
Takis Srl
Università degli Studi di Napoli “Federico II” – Centro di Ricerca Interdipartimentale sui Biomateriali
Università degli Studi di Napoli “Federico II” – Dipartimento di Farmacia
Università degli Studi di Napoli “Federico II” – Dipartimento di Scienze Chimiche
Università degli Studi di Salerno – Dipartimento di Farmacia
Unlimited Technology Srl